News

Home
Resources
Literature Updates
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Back to list

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

10 Dec 2020 9:23 PM | Michele O'Bright (Administrator)

Takashi Kojima , MD; Manish A. Shah , MD; Kei Muro, MD; Eric Francois; Antoine Adenis, MD, PhD; Chih-Hung Hsu, MD, PhD

Read the full abstract...

Add comment

Affiliated Societies

International Interdisciplinary Everything Esophageal

The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net